Breaking News
BREAKING: DOJ Signs Cannabis into Schedule III
WASHINGTON – Today, the federal government took its most consequential ...
Dutch Cannabis Supply Pilot Delivers Lower Prices and a Fuller Shelf
AMSTERDAM – A report published by the Trimbos Institute, RAND ...
Cannara Secures Upgraded $80M Credit Line
MONTREAL – Cannara Biotech Inc. announced that its operating subsidiary ...
UN Approves WHO Recommendation On Rescheduling Medical Cannabis
In a move that could have a massive impact on marijuana reform efforts worldwide, the United Nations Commission on Narcotic Drugs (CND) has accepted a recommendation put forth by the World Health Organization (WHO) to ...
NEWS: Psilocybin Could Help Prevent Debilitating Nerve Damage Caused by Chemotherapy
AUSTIN – A new study from The University of Texas MD Anderson Cancer Center suggests that psilocybin, the psychedelic compound found in certain mushrooms, could eventually help prevent one of chemotherapy’s most painful and persistent side ...
Elixinol Offloads Its US Hemp Business to Ananda Health
SYDNEY – Australian Elixinol Wellness Limited has entered into a binding asset purchase agreement with Ananda Health to sell its wholly-owned subsidiary, Elixinol LLC, effectively exiting the United States hemp market. Under the transaction terms, ...
ARPA-H Launches ASCENT-IBO Initiative for Ibogaine Clinical Research
WASHINGTON – The Advanced Research Projects Agency for Health (ARPA-H) has launched a federal research opportunity aimed at accelerating clinical evaluations of ibogaine for Opioid Use Disorder (OUD). Titled ASCENT-IBO, short for Accelerating Safe Clinical ...
